Daily Briefing · 2026-09-05

US military strikes on Iranian oil tankers are threatening global oil supplies, stoking fears of higher energy prices and renewed inflation pressure. On a more hopeful note, Trump administration envoys have traveled to Moscow carrying a Ukraine peace proposal, a development that could ease tensions and help stabilize commodity markets. Closer to home, a public order incident briefly shut down all transport routes at Dover port, disrupting supply chains before services were restored. On the macro front, markets are still digesting August's jobs report, with investors debating whether the Fed will deliver just one rate cut. The Federal Reserve is heading into one of its most divided votes in a decade, adding a fresh layer of uncertainty to the policy outlook. Attention is now shifting to upcoming inflation data, which could determine whether the socalled Goldilocks scenario for markets holds up. In banking, JPMorgan's five trillion dollar asset base continues to deliver strong results, though elevated valuation multiples are seen limiting nearterm upside for the stock. In healthcare, Bristol Myers Squibb is seeing momentum from new drug launches and acquisitions, a portfolio renewal strategy expected to offset patent cliff losses. In dealmaking, Teledyne's roughly three hundred five million dollar acquisition of Everspin Technologies is being viewed as validation of MRAM technology's strategic value in industrial applications. On the tech side, Innodata's premium valuation is being justified by accelerating revenue growth and improving margins, prompting an analyst rating upgrade. And a word of caution for job seekers — AIpowered recruitment scams are becoming increasingly convincing, driving up fraud losses tied to fake job offers.